
Merck & Co Inc
MRK86.810USD
+0.210+0.24%
Giờ giao dịch (ET)Báo giá bị trễ 15 phút
219.42BVốn hóa
12.82P/E TTM
Thông tin về Merck & Co Inc Công ty
Merck & Co., Inc. is a research-intensive biopharmaceutical company engaged in research to deliver health solutions that advance the prevention and treatment of diseases in people and animals. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. It is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Thông tin công ty
Mã công tyMRK
Tên công tyMerck & Co Inc
Ngày IPOJan 01, 1941
Được thành lập tại1970
Tổng giám đốc điều hànhMr. Robert M. (Rob) Davis
Số lượng nhân viên75000
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJan 01
Địa chỉ2000 Galloping Hill Road
Thành phốKENILWORTH
Sàn giao dịch chứng khoánNYSE Consolidated
Quốc giaUnited States of America
Mã bưu điện07033
Điện thoại19087404000
Trang webhttps://www.merck.com/
Mã công tyMRK
Ngày IPOJan 01, 1941
Được thành lập tại1970
Cán bộ điều hành công ty
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
+27.35%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
185.33K
+17.90%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
78.86K
+70.54%
Ms. Caroline Litchfield
Ms. Caroline Litchfield
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
74.34K
+46.03%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
66.61K
+73.22%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.42K
+90.81%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Executive Vice President, Chief Strategy Officer
Executive Vice President, Chief Strategy Officer
23.22K
+1.98%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
20.72K
+5.86%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Xem Thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
+27.35%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
185.33K
+17.90%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
78.86K
+70.54%
Ms. Caroline Litchfield
Ms. Caroline Litchfield
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
74.34K
+46.03%
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
66.61K
+73.22%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.42K
+90.81%
Phân tích doanh thu
Tiền tệ: USDThời gian cập nhật: 22 giờ trước
Tiền tệ: USDThời gian cập nhật: 22 giờ trước
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Theo doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Oncology-Keytruda
29.48B
45.95%
Vaccines -Gardasil/Gardasil
8.58B
13.38%
Animal Health-Livestock
3.46B
5.39%
Other pharmaceutical
2.51B
3.91%
Vaccines -ProQuad/M-M-R II/Varivax
2.48B
3.87%
Other
17.65B
27.50%
Theo khu vựcUSD
Tên
Doanh thu
Tỷ trọng
United States
32.28B
50.30%
Europe, Middle East and Africa
14.04B
21.88%
China
5.49B
8.56%
Latin America
3.46B
5.39%
Japan
3.28B
5.11%
Other
5.62B
8.75%
Theo doanh nghiệp
Theo khu vực
Theo doanh nghiệpUSD
Tên
Doanh thu
Tỷ trọng
Oncology-Keytruda
29.48B
45.95%
Vaccines -Gardasil/Gardasil
8.58B
13.38%
Animal Health-Livestock
3.46B
5.39%
Other pharmaceutical
2.51B
3.91%
Vaccines -ProQuad/M-M-R II/Varivax
2.48B
3.87%
Other
17.65B
27.50%
Cổ đông
Thời gian cập nhật: T3, 11 Th03
Thời gian cập nhật: T3, 11 Th03
Cổ đông Thống kê
Loại
Cổ đông Thống kê
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.03%
BlackRock Institutional Trust Company, N.A.
5.68%
State Street Global Advisors (US)
4.79%
Wellington Management Company, LLP
3.20%
Geode Capital Management, L.L.C.
2.42%
Other
73.89%
Cổ đông Thống kê
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.03%
BlackRock Institutional Trust Company, N.A.
5.68%
State Street Global Advisors (US)
4.79%
Wellington Management Company, LLP
3.20%
Geode Capital Management, L.L.C.
2.42%
Other
73.89%
Loại
Cổ đông
Tỷ trọng
Investment Advisor/Hedge Fund
35.88%
Investment Advisor
31.49%
Research Firm
3.76%
Pension Fund
2.96%
Bank and Trust
2.38%
Hedge Fund
1.52%
Sovereign Wealth Fund
1.49%
Insurance Company
0.69%
Family Office
0.11%
Other
19.72%
Cổ phần của tổ chức
Thời gian cập nhật: T5, 20 Th02
Thời gian cập nhật: T5, 20 Th02
Kỳ báo cáo
Số lượng tổ chức
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
2025Q1
5308
2.05B
81.06%
+16.18M
2024Q4
5410
2.04B
80.88%
+11.87M
2024Q3
5200
2.01B
79.47%
-7.96M
2024Q2
5181
2.01B
79.28%
-4.86M
2024Q1
5154
2.00B
78.88%
-6.10M
2023Q4
5065
1.99B
78.60%
+584.81K
2023Q3
4871
1.98B
78.17%
-32.03M
2023Q2
4864
2.00B
78.94%
-18.54M
2023Q1
4818
1.99B
78.43%
-16.95M
2022Q4
4785
1.98B
77.94%
-5.23M
Xem Thêm
Hoạt động của cổ đông
Tên
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
Thay đổi %
Ngày
The Vanguard Group, Inc.
253.26M
10.03%
+3.27M
+1.31%
Feb 28, 2025
BlackRock Institutional Trust Company, N.A.
143.39M
5.68%
+10.26M
+7.71%
Dec 31, 2024
State Street Global Advisors (US)
120.91M
4.79%
+1.88M
+1.58%
Dec 31, 2024
Wellington Management Company, LLP
80.74M
3.2%
+4.93M
+6.51%
Dec 31, 2024
Geode Capital Management, L.L.C.
61.18M
2.42%
+2.03M
+3.43%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
34.98M
1.38%
+1.17M
+3.47%
Dec 31, 2024
Fidelity Management & Research Company LLC
33.58M
1.33%
-11.95M
-26.24%
Dec 31, 2024
BofA Global Research (US)
23.08M
0.91%
-1.38M
-5.65%
Dec 31, 2024
BlackRock Asset Management Ireland Limited
21.22M
0.84%
+1.34M
+6.77%
Dec 31, 2024
Morgan Stanley Smith Barney LLC
20.63M
0.82%
-290.99K
-1.39%
Dec 31, 2024
Xem Thêm
ETF liên quan
Thời gian cập nhật: T4, 2 Th04
Thời gian cập nhật: T4, 2 Th04
Tên
Tỷ trọng
FT Vest DJIA Dogs 10 Target Income ETF
11.99%
First Trust NASDAQ Pharmaceuticals ETF
6.57%
ProShares Pet Care ETF
5.23%
TBG Dividend Focus ETF
4.77%
Amplify Weight Loss Drug & Treatment ETF
4.76%
VanEck Pharmaceutical ETF
4.61%
Invesco Pharmaceuticals ETF
4.51%
Tema Oncology ETF
4.49%
ProShares Smart Materials ETF
4.3%
Proshares Ultra Health Care
4.3%
Xem Thêm
FT Vest DJIA Dogs 10 Target Income ETF
Tỷ trọng11.99%
First Trust NASDAQ Pharmaceuticals ETF
Tỷ trọng6.57%
ProShares Pet Care ETF
Tỷ trọng5.23%
TBG Dividend Focus ETF
Tỷ trọng4.77%
Amplify Weight Loss Drug & Treatment ETF
Tỷ trọng4.76%
VanEck Pharmaceutical ETF
Tỷ trọng4.61%
Invesco Pharmaceuticals ETF
Tỷ trọng4.51%
Tema Oncology ETF
Tỷ trọng4.49%
ProShares Smart Materials ETF
Tỷ trọng4.3%
Proshares Ultra Health Care
Tỷ trọng4.3%
Cổ tức
Tổng cộng
35.12B
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
Ngày
Cổ tức
Ngày ghi sổ
Ngày thanh toán
Ngày không hưởng cổ tức
Jan 28, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Apr 07, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Apr 07, 2025
Mar 17, 2025
Nov 19, 2024
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Jan 08, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 08, 2025
Dec 16, 2024
Jul 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Oct 07, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 07, 2024
Sep 16, 2024
May 29, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Jul 08, 2024 going ex on Jun 17, 2024
Jun 17, 2024
Jul 08, 2024
Jun 17, 2024
Jan 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Nov 28, 2023
MRK.NB Final Cash Dividend of gross USD 0.77 paid on Jan 08, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 08, 2024
Dec 14, 2023
Jul 25, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Oct 06, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 06, 2023
Sep 14, 2023
May 23, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Jul 10, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 10, 2023
Jun 14, 2023
Jan 24, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Apr 10, 2023 going ex on Mar 14, 2023
Mar 15, 2023
Apr 10, 2023
Mar 14, 2023
Nov 30, 2022
MRK.NB Final Cash Dividend of gross USD 0.73 paid on Jan 09, 2023 going ex on Dec 14, 2022
Dec 15, 2022
Jan 09, 2023
Dec 14, 2022
Xem Thêm
Chia tách cổ phiếu
Ngày
Loại
Tỷ lệ

Không có dữ liệu
Ngày
Loại
Tỷ lệ

Không có dữ liệu